Medicinova Inc
MNOV- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001226616
No open-market purchases or sales by Medicinova Inc insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $6.84M in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Medicinova Inc as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 42
- +4 vs. Q3 2021
- Shares held
- 7.62M
- −12.8K (−0.2%) vs. Q3 2021
- Total value
- $20.4M
- −$8.52M (−29.4%) vs. Q3 2021
- New holders
- 9
- 15 more added
- Sold out
- 5
- 10 more reduced
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MNOV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 29 | $6.84M |
| Q1 2026 | 30 | $7.40M |
| Q4 2025 | 33 | $6.88M |
| Q3 2025 | 26 | $6.49M |
| Q2 2025 | 23 | $6.77M |
| Q1 2025 | 28 | $7.60M |
| Q4 2024 | 30 | $11.0M |
| Q3 2024 | 30 | $10.4M |
| Q2 2024 | 33 | $7.04M |
| Q1 2024 | 35 | $6.78M |
| Q4 2023 | 34 | $7.25M |
| Q3 2023 | 30 | $10.5M |
| Q2 2023 | 34 | $12.4M |
| Q1 2023 | 40 | $12.1M |
| Q4 2022 | 41 | $12.7M |
| Q3 2022 | 35 | $14.9M |
| Q2 2022 | 35 | $17.6M |
| Q1 2022 | 32 | $19.0M |
| Q4 2021 | 42 | $20.4M |
| Q3 2021 | 39 | $29.0M |
| Q2 2021 | 55 | $35.8M |
| Q1 2021 | 60 | $59.5M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Medicinova Inc; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 1,837,181 | $4.92M | 0.00% | +10,529+0.6% | Added |
| Essex Woodlands Management, Inc. | 1,105,941 | $2.96M | 0.67% | 00.0% | Unchanged |
| BlackRock Inc. | 731,892 | $1.96M | 0.00% | −414,078−36.1% | Reduced |
| Geode Capital Management, LLC | 450,666 | $1.21M | 0.00% | +12,885+2.9% | Added |
| Citigroup Inc | 447,957 | $1.20M | 0.00% | −2,495−0.6% | Reduced |
| Millennium Management LLC | 391,219 | $1.05M | 0.00% | +11,200+2.9% | Added |
| JPMorgan Chase & Co | 301,166 | $807.0K | 0.00% | +24,021+8.7% | Added |
| Susquehanna International Group, LLP | 276,278 | $740.0K | 0.00% | +94,937+52.4% | Added |
| Bridgeway Capital Management, LLC | 220,147 | $590.0K | 0.01% | +39,900+22.1% | Added |
| Bank of America Corp | 211,558 | $567.0K | 0.00% | +67,114+46.5% | Added |
| UBS Group AG | 189,202 | $507.0K | 0.00% | +169,930+881.7% | Added |
| Barclays PLC | 172,800 | $463.0K | 0.00% | +18,784+12.2% | Added |
| Northern Trust Corp | 162,798 | $437.0K | 0.00% | +11,602+7.7% | Added |
| Renaissance Technologies LLC | 142,300 | $381.0K | 0.00% | +13,300+10.3% | Added |
| State Street Corp | 132,849 | $356.0K | 0.00% | 00.0% | Unchanged |
| Anson Funds Management LP | 131,495 | $352.0K | 0.05% | +131,495 | New |
| Bank of New York Mellon Corp | 121,045 | $324.0K | 0.00% | 00.0% | Unchanged |
| Marshall Wace, LLP | 110,200 | $295.0K | 0.00% | −174,502−61.3% | Reduced |
| Dimensional Fund Advisors LP | 54,855 | $147.0K | 0.00% | +323+0.6% | Added |
| Capricorn Fund Managers Ltd | 53,700 | $144.0K | 0.04% | +53,700 | New |
| Schonfeld Strategic Advisors LLC | 44,600 | $119.0K | 0.00% | +44,600 | New |
| HRT Financial LP | 42,945 | $115.0K | 0.00% | −63,134−59.5% | Reduced |
| Goldman Sachs Group Inc | 33,516 | $90.0K | 0.00% | −869−2.5% | Reduced |
| Price T Rowe Associates Inc | 31,500 | $84.0K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 29,542 | $79.0K | 0.00% | +29,542 | New |
| Ameriprise Financial Inc | 27,200 | $73.0K | 0.00% | −7,500−21.6% | Reduced |
| Citadel Advisors LLC | 24,160 | $65.0K | 0.00% | +11,028+84.0% | Added |
| Morgan Stanley | 21,441 | $57.0K | 0.00% | −11,071−34.1% | Reduced |
| Occudo Quantitative Strategies LP | 18,988 | $51.0K | 0.00% | −821−4.1% | Reduced |
| Bank Julius Baer & Co. Ltd, Zurich | 19,000 | $51.0K | 0.00% | +19,000 | New |
| Charles Schwab Investment Management Inc | 17,843 | $48.0K | 0.00% | 00.0% | Unchanged |
| Blankinship & Foster, LLC | 15,700 | $42.0K | 0.02% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 13,797 | $37.0K | 0.00% | +13,797 | New |
| WealthTrust Axiom LLC | 12,500 | $33.0K | 0.01% | 00.0% | Unchanged |
| Ergoteles LLC | 10,460 | $28.0K | 0.00% | −84,035−88.9% | Reduced |
| Buckingham Strategic Partners | 10,000 | $27.0K | 0.01% | +10,000 | New |
| Cutler Group LP | 2,100 | $5.00K | 0.00% | +100+5.0% | Added |
| BNP Paribas Arbitrage, SA | 1,350 | $3.62K | 0.00% | +515+61.7% | Added |
| Eaton Vance Management | 1,100 | $3.00K | 0.00% | +1,100 | New |
| Tower Research Capital LLC (TRC) | 263 | $1.00K | 0.00% | −5,788−95.7% | Reduced |
| Northwestern Mutual Wealth Management Co | 305 | $1.00K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 320 | $1.00K | 0.00% | +320 | New |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −13,718−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −12,847−100.0% | Sold out |
| ProShare Advisors LLC | 0 | $0 | 0.00% | −10,461−100.0% | Sold out |
| Penserra Capital Management LLC | 0 | $0 | 0.00% | −1,120−100.0% | Sold out |
| Daiwa Securities Group Inc. | 0 | $0 | 0.00% | −84−100.0% | Sold out |
| Marshall Wace North America L.P. | – | – | – | – | Not filed |